Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,105.00
-21.80 (-1.93%)
At close: May 29, 2026, 4:00 PM EDT
1,103.63
-1.38 (-0.12%)
After-hours: May 29, 2026, 7:59 PM EDT
Eli Lilly Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 72,250 | 65,179 | 45,043 | 34,124 | 28,541 | 28,318 | |
Revenue Growth (YoY) | 47.44% | 44.70% | 32.00% | 19.56% | 0.79% | 15.40% |
Cost of Revenue | 12,405 | 11,052 | 8,418 | 7,082 | 6,630 | 7,313 |
Gross Profit | 59,844 | 54,127 | 36,625 | 27,042 | 21,912 | 21,006 |
Selling, General & Admin | 11,560 | 11,094 | 8,594 | 7,404 | 6,440 | 6,432 |
Research & Development | 16,036 | 16,247 | 14,271 | 13,113 | 8,099 | 7,901 |
Other Operating Expenses | 727.9 | 484 | 861 | 68 | 244.6 | 316.1 |
Total Operating Expenses | 28,324 | 27,825 | 23,726 | 20,585 | 14,784 | 14,649 |
Operating Income | 15,738 | 26,302 | 12,899 | 6,457 | 7,127 | 6,357 |
Interest Income | -237.7 | - | - | - | - | - |
Other Non-Operating Income (Expense) | 82.1 | -571 | -219 | 97 | -320.9 | -201.6 |
Total Non-Operating Income (Expense) | -155.6 | -571 | -219 | 97 | -320.9 | -201.6 |
Pretax Income | 31,124 | 25,731 | 12,680 | 6,554 | 6,806 | 6,156 |
Provision for Income Taxes | 5,849 | 5,091 | 2,090 | 1,314 | 561.6 | 573.8 |
Net Income | 25,275 | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income to Common | 25,275 | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income Growth | 127.58% | 94.90% | 102.10% | -16.09% | 11.88% | -9.88% |
Shares Outstanding (Basic) | 897 | 897 | 901 | 900 | 902 | 907 |
Shares Outstanding (Diluted) | 898 | 899 | 904 | 903 | 905 | 912 |
Shares Change (YoY) | -0.57% | -0.53% | 0.09% | -0.15% | -0.78% | -0.09% |
EPS (Basic) | 28.18 | 23.00 | 11.76 | 5.82 | 6.93 | 6.15 |
EPS (Diluted) | 28.15 | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 |
EPS Growth | 129.05% | 95.99% | 101.90% | -15.94% | 12.75% | -9.87% |
Shares Outstanding | 894.5 | 894.8 | 897.54 | 899.38 | 900.18 | 903.65 |
Free Cash Flow | 11,823 | 8,972 | 3,760 | 792 | 5,731 | 6,056 |
Free Cash Flow Growth | 31.78% | 138.62% | 374.75% | -86.18% | -5.36% | 18.48% |
Free Cash Flow Per Share | 13.16 | 9.98 | 4.16 | 0.88 | 6.34 | 6.64 |
Dividends Per Share | 6.230 | 6.000 | 5.200 | 4.520 | 3.920 | 3.400 |
Dividend Growth | 3.83% | 15.38% | 15.04% | 15.31% | 15.29% | 14.87% |
Gross Margin | 82.83% | 83.04% | 81.31% | 79.25% | 76.77% | 74.18% |
Operating Margin | 21.78% | 40.35% | 28.64% | 18.92% | 24.97% | 22.45% |
Profit Margin | 34.98% | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% |
FCF Margin | 16.36% | 13.77% | 8.35% | 2.32% | 20.08% | 21.39% |
EBITDA | 17,781 | 28,299 | 14,666 | 7,984 | 8,650 | 7,905 |
EBITDA Margin | 24.61% | 43.42% | 32.56% | 23.40% | 30.31% | 27.91% |
EBIT | 15,738 | 26,302 | 12,899 | 6,457 | 7,127 | 6,357 |
EBIT Margin | 21.78% | 40.35% | 28.64% | 18.92% | 24.97% | 22.45% |
Effective Tax Rate | 18.79% | 19.79% | 16.48% | 20.05% | 8.25% | 9.32% |